Top compounds associated with response to NEURL2


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib GDSC1000 pan-cancer AAC -0.087 0.01
mRNA paclitaxel CCLE pan-cancer AAC -0.1 0.02
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.077 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA lapatinib gCSI pan-cancer AAC -0.14 0.02
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.091 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.08 0.02
mRNA embelin GDSC1000 pan-cancer AAC -0.084 0.02
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.073 0.02
Download CSV